
Farley J. Abad
Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )
| Most Active Art Unit | 2181 |
| Art Unit(s) | 2181 |
| Total Applications | 1076 |
| Issued Applications | 864 |
| Pending Applications | 101 |
| Abandoned Applications | 140 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7322426
[patent_doc_number] => 20040137016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Pre-S protein of hepatitis B virus (HBV) as an adjuvant and a component of HBV vaccine'
[patent_app_type] => new
[patent_app_number] => 10/720662
[patent_app_country] => US
[patent_app_date] => 2003-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7102
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137016.pdf
[firstpage_image] =>[orig_patent_app_number] => 10720662
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/720662 | Pre-S protein of hepatitis B virus (HBV) as an adjuvant and a component of HBV vaccine | Nov 23, 2003 | Abandoned |
Array
(
[id] => 586343
[patent_doc_number] => 07439058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-21
[patent_title] => 'HBV/HCV virus-like particle'
[patent_app_type] => utility
[patent_app_number] => 10/715665
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 15608
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/439/07439058.pdf
[firstpage_image] =>[orig_patent_app_number] => 10715665
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/715665 | HBV/HCV virus-like particle | Nov 16, 2003 | Issued |
Array
(
[id] => 5834260
[patent_doc_number] => 20060246090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Vaccine against hcv'
[patent_app_type] => utility
[patent_app_number] => 10/535047
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 13561
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246090.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535047
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535047 | Vaccine against hcv | Nov 12, 2003 | Abandoned |
Array
(
[id] => 5865465
[patent_doc_number] => 20060099595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Highly permissive cell lines for hepatitis c virus replication'
[patent_app_type] => utility
[patent_app_number] => 10/534571
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9328
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099595.pdf
[firstpage_image] =>[orig_patent_app_number] => 10534571
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/534571 | Highly permissive cell lines for hepatitis C virus RNA replication | Nov 12, 2003 | Issued |
Array
(
[id] => 7427879
[patent_doc_number] => 20040209283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Continuous-read assay for the detection of de novo HCV RNA polymerase activity'
[patent_app_type] => new
[patent_app_number] => 10/712479
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 4695
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20040209283.pdf
[firstpage_image] =>[orig_patent_app_number] => 10712479
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/712479 | Continuous-read assay for the detection of de novo HCV RNA polymerase activity | Nov 12, 2003 | Abandoned |
Array
(
[id] => 7153888
[patent_doc_number] => 20050026141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Taxonomic identification of pathogenic microorganisms and their toxic proteins'
[patent_app_type] => utility
[patent_app_number] => 10/706544
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5518
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026141.pdf
[firstpage_image] =>[orig_patent_app_number] => 10706544
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/706544 | Taxonomic identification of pathogenic microorganisms and their toxic proteins | Nov 11, 2003 | Abandoned |
Array
(
[id] => 7033606
[patent_doc_number] => 20050032115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Taxonomic identification of pathogenic microorganisms and their toxic proteins'
[patent_app_type] => utility
[patent_app_number] => 10/706543
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5518
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032115.pdf
[firstpage_image] =>[orig_patent_app_number] => 10706543
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/706543 | Taxonomic identification of pathogenic microorganisms and their toxic proteins | Nov 11, 2003 | Abandoned |
Array
(
[id] => 7153885
[patent_doc_number] => 20050026140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Taxonomic identification of pathogenic microorganisms and their toxic proteins'
[patent_app_type] => utility
[patent_app_number] => 10/706542
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5519
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10706542
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/706542 | Taxonomic identification of pathogenic microorganisms and their toxic proteins | Nov 11, 2003 | Abandoned |
Array
(
[id] => 7263824
[patent_doc_number] => 20040241806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'G-CSF polypeptides and conjugates'
[patent_app_type] => new
[patent_app_number] => 10/705745
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 31827
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10705745
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/705745 | G-CSF polypeptides and conjugates | Nov 9, 2003 | Abandoned |
Array
(
[id] => 7678091
[patent_doc_number] => 20040151735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'HCV compositions'
[patent_app_type] => new
[patent_app_number] => 10/703086
[patent_app_country] => US
[patent_app_date] => 2003-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15278
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20040151735.pdf
[firstpage_image] =>[orig_patent_app_number] => 10703086
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/703086 | HCV compositions | Nov 6, 2003 | Abandoned |
Array
(
[id] => 466994
[patent_doc_number] => 07235394
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-06-26
[patent_title] => 'Functional DNA clone for hepatitis C virus (HCV) and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/704407
[patent_app_country] => US
[patent_app_date] => 2003-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 13
[patent_no_of_words] => 36321
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/235/07235394.pdf
[firstpage_image] =>[orig_patent_app_number] => 10704407
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/704407 | Functional DNA clone for hepatitis C virus (HCV) and uses thereof | Nov 5, 2003 | Issued |
Array
(
[id] => 5148270
[patent_doc_number] => 20070048329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor'
[patent_app_type] => utility
[patent_app_number] => 10/533726
[patent_app_country] => US
[patent_app_date] => 2003-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14948
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048329.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533726
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533726 | Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor | Nov 2, 2003 | Abandoned |
Array
(
[id] => 7201645
[patent_doc_number] => 20040086850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Methods for the identification of antiviral compounds'
[patent_app_type] => new
[patent_app_number] => 10/698086
[patent_app_country] => US
[patent_app_date] => 2003-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 9741
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086850.pdf
[firstpage_image] =>[orig_patent_app_number] => 10698086
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/698086 | Methods for the identification of antiviral compounds | Oct 29, 2003 | Issued |
Array
(
[id] => 1037182
[patent_doc_number] => 06872396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-29
[patent_title] => 'Specificity in the detection of anti-rubella IGM antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/696635
[patent_app_country] => US
[patent_app_date] => 2003-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5656
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872396.pdf
[firstpage_image] =>[orig_patent_app_number] => 10696635
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/696635 | Specificity in the detection of anti-rubella IGM antibodies | Oct 28, 2003 | Issued |
Array
(
[id] => 7675364
[patent_doc_number] => 20040126754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes'
[patent_app_type] => new
[patent_app_number] => 10/685435
[patent_app_country] => US
[patent_app_date] => 2003-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14973
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0126/20040126754.pdf
[firstpage_image] =>[orig_patent_app_number] => 10685435
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/685435 | Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes | Oct 15, 2003 | Abandoned |
Array
(
[id] => 7251814
[patent_doc_number] => 20040259108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Compositions and methods for detecting west nile virus'
[patent_app_type] => new
[patent_app_number] => 10/688489
[patent_app_country] => US
[patent_app_date] => 2003-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 28276
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259108.pdf
[firstpage_image] =>[orig_patent_app_number] => 10688489
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/688489 | Compositions and methods for detecting West Nile virus | Oct 15, 2003 | Issued |
Array
(
[id] => 7323455
[patent_doc_number] => 20040137430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Assays to detect or quantify bacterial or viral pathogens and contaminants'
[patent_app_type] => new
[patent_app_number] => 10/685925
[patent_app_country] => US
[patent_app_date] => 2003-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11726
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137430.pdf
[firstpage_image] =>[orig_patent_app_number] => 10685925
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/685925 | Assays to detect or quantify bacterial or viral pathogens and contaminants | Oct 14, 2003 | Abandoned |
Array
(
[id] => 5085398
[patent_doc_number] => 20070275449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Method for Large-Scale Production, Isolation, Purification and the Uses of Multi-Type Recombinant Adeno-Associated Virus Vectors'
[patent_app_type] => utility
[patent_app_number] => 10/576000
[patent_app_country] => US
[patent_app_date] => 2003-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 23370
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275449.pdf
[firstpage_image] =>[orig_patent_app_number] => 10576000
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/576000 | Method for Large-Scale Production, Isolation, Purification and the Uses of Multi-Type Recombinant Adeno-Associated Virus Vectors | Oct 14, 2003 | Abandoned |
Array
(
[id] => 7471025
[patent_doc_number] => 20040121466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Alphavirus RNA replicon systems'
[patent_app_type] => new
[patent_app_number] => 10/683781
[patent_app_country] => US
[patent_app_date] => 2003-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9077
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20040121466.pdf
[firstpage_image] =>[orig_patent_app_number] => 10683781
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/683781 | Alphavirus RNA replicon systems | Oct 9, 2003 | Abandoned |
Array
(
[id] => 6990804
[patent_doc_number] => 20050089841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Induction of a Th1-like response in vitro'
[patent_app_type] => utility
[patent_app_number] => 10/679956
[patent_app_country] => US
[patent_app_date] => 2003-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 15631
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089841.pdf
[firstpage_image] =>[orig_patent_app_number] => 10679956
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/679956 | Induction of a Th1-like response in vitro | Oct 5, 2003 | Abandoned |